Vision - Move military relevant medical solutions forward in the acquisition life-cycle to meet the needs of Service members and other military health system beneficiaries

Joint Warfighter Medical Program Annual Report

» Click on Image to View Program Annual Report

The Joint Warfighter Medical Research Program (JWMRP) is a resource for the Department of Defense (DoD) to advance the outcomes of previously funded Congressional Special Interest medical research and development (R&D) projects addressing the military medical requirements of the Services. The JWMRP complements the Defense Medical R&D Program (DMRDP) by facilitating the further development of promising medical solutions through the acquisition process.

Each year, a broad spectrum of research and product development efforts are considered for funding under the JWMRP. The research is aligned to one of the six DMRDP Joint Program Committee (JPC) scientific domains listed below:

The U.S. Congress first appropriated funds for the JWMRP in Fiscal Year (FY) 2012. Since that time, 109 awards or award modifications have been funded through the JWMRP in two major project categories: advanced technology development projects and demonstration/validation projects. Projects in advanced technology development focus on systematic application of knowledge toward the production of potential medical solutions. Demonstration/validation projects focus on the demonstration and validation of performance parameters of potential products to support their transition toward clinical utility. By supporting both advanced technology development and demonstration/validation efforts, the JWMRP offers a pathway for transitioning promising medical solutions from the laboratory toward the clinic for the benefit of our Service members, other military health system beneficiaries, and the American public.

The JWMRP supports research projects across several research topics and disciplines. Research and product development efforts funded by the JWMRP include the following:

  • Development of a transportable pathogen reduction and blood safety system
  • Prototype development and testing of a miniaturized, remotely controlled, image guided surgical robot for peritoneal cavity surgery
  • Development of a non-electric, disposable IV infusion pump
  • Intelligent tutoring system for emergency preparedness training
  • Phase III pivotal clinical trial for a Norovirus vaccine
  • Phase II Malaria clinical trial with the first live attenuated vaccine against protozoal disease in humans
  • Development of a passive physiological monitoring system for use during medical evacuation
  • Development and clinical trial of a food supplement to prevent travelers' diarrhea
  • Development and evaluation of implantable nanosensors to monitor key physiological parameters of warfighter health
  • Pivotal study on the regulatory approval pathway for a drug to treat acute radiation syndrome
  • Accelerating the development of the opioid Sufentanil for pain treatment
  • Development of bioengineered corneas for transplantation

Congressional Appropriations

Congressional Appropriations

  • $400 million
  • $50 million

Funding Summary


news_icon News & Highlights


Move military relevant medical solutions forward in the acquisition life-cycle to meet the needs of Service members and other military health system beneficiaries


Accelerate research and development projects that have the potential to close high priority Department of Defense medical capability gaps

Last updated Wednesday, June 5, 2019